Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT07379151
Evaluation of the Antibody Persistence Beyond Five Years After Immunization With MenFiveTM (NmCV-5), a Pentavalent Meningococcal ACYWX Conjugate Vaccine
Sponsor: Serum Institute of India Pvt. Ltd.
View on ClinicalTrials.gov
Summary
This study will measure immune persistence of the NmCV-5 more than 5 years after a single dose vaccination in participants 2-29 years of age in Mali and The Gambia.
Official title: Evaluation of the Antibody Persistence in African Participants Beyond Five Years After Immunization With MenFiveTM (NmCV-5), a Pentavalent Meningococcal ACYWX Conjugate Vaccine
Key Details
Gender
All
Age Range
7 Years - 36 Years
Study Type
OBSERVATIONAL
Enrollment
450
Start Date
2026-03
Completion Date
2026-12
Last Updated
2026-02-04
Healthy Volunteers
Yes